Amgen Inc (AMGN)
286.31
+4.54
(+1.61%)
USD |
NASDAQ |
Mar 27, 16:00
287.84
+1.53
(+0.53%)
After-Hours: 04:44
Amgen Gross Profit (TTM): 19.74B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 19.74B |
September 30, 2023 | 19.75B |
June 30, 2023 | 19.71B |
March 31, 2023 | 19.62B |
December 31, 2022 | 19.92B |
September 30, 2022 | 19.95B |
June 30, 2022 | 19.99B |
March 31, 2022 | 19.79B |
December 31, 2021 | 19.52B |
September 30, 2021 | 19.43B |
June 30, 2021 | 19.20B |
March 31, 2021 | 19.03B |
December 31, 2020 | 19.26B |
September 30, 2020 | 19.17B |
June 30, 2020 | 19.01B |
March 31, 2020 | 19.15B |
December 31, 2019 | 19.01B |
September 30, 2019 | 19.20B |
June 30, 2019 | 19.36B |
March 31, 2019 | 19.54B |
December 31, 2018 | 19.65B |
September 30, 2018 | 19.26B |
June 30, 2018 | 19.17B |
March 31, 2018 | 18.92B |
December 31, 2017 | 18.78B |
Date | Value |
---|---|
September 30, 2017 | 18.94B |
June 30, 2017 | 18.94B |
March 31, 2017 | 18.79B |
December 31, 2016 | 18.83B |
September 30, 2016 | 18.40B |
June 30, 2016 | 18.30B |
March 31, 2016 | 17.94B |
December 31, 2015 | 17.44B |
September 30, 2015 | 17.12B |
June 30, 2015 | 16.39B |
March 31, 2015 | 16.21B |
December 31, 2014 | 15.64B |
September 30, 2014 | 15.48B |
June 30, 2014 | 15.47B |
March 31, 2014 | 15.27B |
December 31, 2013 | 15.33B |
September 30, 2013 | 14.85B |
June 30, 2013 | 14.43B |
March 31, 2013 | 14.26B |
December 31, 2012 | 14.07B |
September 30, 2012 | 13.60B |
June 30, 2012 | 13.40B |
March 31, 2012 | 13.03B |
December 31, 2011 | 12.87B |
September 30, 2011 | 13.11B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
19.01B
Minimum
Dec 2019
19.99B
Maximum
Jun 2022
19.47B
Average
19.48B
Median
Gross Profit (TTM) Benchmarks
Gilead Sciences Inc | 20.62B |
Johnson & Johnson | 63.01B |
Eli Lilly and Co | 27.04B |
Merck & Co Inc | 43.99B |
Vertex Pharmaceuticals Inc | 8.607B |